Document Detail


Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial.
MedLine Citation:
PMID:  21315217     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The antiarrhythmic effects of n-3 polyunsaturated fatty acids (n-3PUFA) in ischemic heart disease have been demonstrated; however, studies in patients surviving malignant ventricular arrhythmias of different etiologies treated with an implantable cardioverter-defibrillator (ICD) have given conflicting results. The purpose of this study was to assess the antiarrhythmic effect of n-3PUFA versus placebo in 566 patients with heart failure enrolled in the GISSI-HF trial who received an ICD for secondary or primary prevention of ventricular fibrillation (VF) or tachycardia (VT).
METHODS: Clinical data and arrhythmic event recordings extracted from the device memory were obtained. We tested the treatment effect by a multivariate Cox model adjusting for all clinical parameters associated with the primary end point defined as time to first appropriate ICD discharge for VT/VF.
RESULTS: In the 566 patients with at least one recorded follow-up visit, 1363 VT and 316 VF episodes were terminated by ICD pacing or shock over a median follow-up of 928 days. The incidence of the primary end point event was 27.3% in the n-3PUFA group and 34.0% in the placebo group (adjusted hazard rate = 0.80, 95% CI 0.59-1.09, P = .152). Patients who received 1, 2 to 3, or >3 ICD discharges were 8.9%, 7.1%, and 11.1% in the n-3PUFA group, compared with slightly higher rates of 11.1%, 10.7%, and 12.1% in the placebo group (overall P = .30). Patients with the highest 3-month increase in plasma n-3PUFA had a somewhat lower incidence of arrhythmic events.
CONCLUSIONS: The results of this study, though not statistically significant, support prior evidences of an antiarrhythmic effect of n-3PUFA in patients with ICD, although they leave open the issue of whether this effect leads to a survival benefit.
Authors:
Andrea A Finzi; Roberto Latini; Simona Barlera; Maria G Rossi; Albarosa Ruggeri; Alessandro Mezzani; Chiara Favero; Maria G Franzosi; Domenico Serra; Donata Lucci; Francesca Bianchini; Roberto Bernasconi; Aldo P Maggioni; Gianluigi Nicolosi; Maurizio Porcu; Gianni Tognoni; Luigi Tavazzi; Roberto Marchioli
Related Documents :
21537737 - Evaluation of pulmonary function in patients submitted to reduction mammaplasty.
21361827 - Shockwave lithotripsy in patients with horseshoe kidney: determinants of success.
21479767 - Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrot...
9818537 - Evaluation of intraocular pressure and cataract formation following the long-term use o...
17889187 - Clinical evolution of heart transplantation in patients with previous valvular cardiomy...
25375267 - Neuroprotection of nalmefene for postoperative patients with spontaneous intracerebral ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  161     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  338-343.e1     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 Mosby, Inc. All rights reserved.
Affiliation:
Unit of Cardiovascular Medicine, Cardiopulmonary Dept, Fondazione Ca' Granda/Policlinico, Milano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation...
Next Document:  Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-se...